Reduced ZO‐1 Expression Is Associated With Structural Atypia in Gastric Crawling‐Type Adenocarcinoma
Open Access
- 18 November 2026
- journal article
- Published by Wiley in Pathology International
- Vol. 76 (11)
Abstract
Gastric crawling‐type adenocarcinoma (CRA) is characterized by the lateral spread of low‐grade neoplastic glands and is frequently accompanied by poorly cohesive carcinoma (PCC) components. However, the molecular basis of its distinctive architecture remains unclear. We investigated the association of E‐cadherin and ZO‐1 expression with CRA and PCC components in 54 moderately differentiated intramucosal gastric tubular adenocarcinomas (22 CRA and 32 non‐CRA). Immunohistochemistry and quantitative multiplex immunofluorescence were used to assess E‐cadherin and ZO‐1 expression in non‐neoplastic mucosa, gland‐forming main tumor components, and PCC components. PCC components were more frequent in CRA than in non‐CRA lesions (50.0% vs. 6.3%, p = 0.001). E‐cadherin was reduced in main tumor components regardless of CRA status. ZO‐1 reduction was more frequent in CRA than in non‐CRA (90.9% vs. 18.8%, p < 0.001); quantitatively, main tumor components of CRA lesions showed lower ZO‐1 expression than main tumor components of non‐CRA lesions ( p < 0.001). Within CRA, PCC components showed lower ZO‐1 expression than corresponding main tumor components ( p < 0.014). Multivariable analysis identified reduced ZO‐1 expression as independently associated with CRA. These findings suggest that altered apicolateral junctional organization may contribute to the structural atypia of CRA and its association with PCC components.This publication has 24 references indexed in Scilit:
- The scaffolding protein ZO-1 coordinates actomyosin and epithelial apical specializations in vitro and in vivoJournal of Biological Chemistry, 2018
- Distinct expression profile of key molecules in crawling-type early gastric carcinomaGastric Cancer, 2016
- Very well-differentiated gastric carcinoma of intestinal type: analysis of diagnostic criteriaLaboratory Investigation, 2013
- “Crawling-type” adenocarcinoma of the stomach: a distinct entity preceding poorly differentiated adenocarcinomaGastric Cancer, 2012
- Loss of tight junction barrier function and its role in cancer metastasisBiochimica et Biophysica Acta (BBA) - Biomembranes, 2009
- Hereditary Diffuse Gastric Cancer: Diagnosis and ManagementClinical Gastroenterology and Hepatology, 2006
- Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlationHuman Pathology, 2005
- Loss of the Tight Junction MAGUK ZO-1 in Breast CancerThe American Journal of Pathology, 1998
- The Tight Junction Protein ZO-1 Establishes a Link between the Transmembrane Protein Occludin and the Actin CytoskeletonJournal of Biological Chemistry, 1998
- Involvement of ZO-1 in Cadherin-based Cell Adhesion through Its Direct Binding to α Catenin and Actin FilamentsJournal of Cell Biology, 1997